Elizabeth Anderson CFA
Stock Analyst at Evercore ISI
(3.44)
# 2,322
Out of 4,579 analysts
567
Total ratings
54.4%
Success rate
2.4%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintained: Hold | $25 → $22 | $20.99 | +4.81% | 31 | Jul 20, 2026 | |
| MDLN Medline | Maintained: Buy | $55 → $48 | $39.70 | +20.91% | 5 | Jul 9, 2026 | |
| GMRS GMR Solutions | Initiated Coverage: Buy | $20 | $12.72 | +57.23% | 1 | Jun 7, 2026 | |
| ELV Elevance Health | Upgraded: Buy | $360 | $378.36 | -4.85% | 3 | May 19, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $350 → $400 | $417.64 | -4.22% | 4 | May 12, 2026 | |
| ALGN Align Technology | Maintained: Buy | $220 | $168.05 | +30.91% | 44 | May 11, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $200 → $220 | $224.30 | -1.92% | 31 | May 8, 2026 | |
| MCK McKesson | Maintained: Buy | $950 → $850 | $850.06 | -0.01% | 30 | May 8, 2026 | |
| OMDA Omada Health | Maintained: Buy | $15 → $20 | $20.58 | -2.82% | 10 | May 8, 2026 | |
| COR Cencora | Maintained: Buy | $360 → $300 | $311.15 | -3.58% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $105 | $107.07 | -1.93% | 37 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $33 | $26.64 | +23.87% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $32 | $98.43 | -67.49% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $24.67 | +5.39% | 17 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $84.61 | +6.37% | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $19.20 | -27.08% | 23 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 | $229.35 | +4.64% | 31 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $301.17 | -0.39% | 15 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $8.91 | -32.66% | 29 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $23.13 | +16.76% | 14 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $75.11 | -40.09% | 8 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $195 → $250 | $381.15 | -34.41% | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $210 | $231.84 | -9.42% | 19 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $13 | $13.02 | -0.15% | 28 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $185 | $213.22 | -13.24% | 21 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.15 | +39.53% | 23 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $240 → $220 | $168.78 | +30.35% | 22 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $8.5 | $1.36 | n/a | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $3 | $0.7248 | n/a | 7 | May 6, 2022 |
Doximity
Jul 20, 2026
Maintained: Hold
Price Target: $25 → $22
Current: $20.99
Upside: +4.81%
Medline
Jul 9, 2026
Maintained: Buy
Price Target: $55 → $48
Current: $39.70
Upside: +20.91%
GMR Solutions
Jun 7, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $12.72
Upside: +57.23%
Elevance Health
May 19, 2026
Upgraded: Buy
Price Target: $360
Current: $378.36
Upside: -4.85%
UnitedHealth Group
May 12, 2026
Maintained: Buy
Price Target: $350 → $400
Current: $417.64
Upside: -4.22%
Align Technology
May 11, 2026
Maintained: Buy
Price Target: $220
Current: $168.05
Upside: +30.91%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $200 → $220
Current: $224.30
Upside: -1.92%
McKesson
May 8, 2026
Maintained: Buy
Price Target: $950 → $850
Current: $850.06
Upside: -0.01%
Omada Health
May 8, 2026
Maintained: Buy
Price Target: $15 → $20
Current: $20.58
Upside: -2.82%
Cencora
May 7, 2026
Maintained: Buy
Price Target: $360 → $300
Current: $311.15
Upside: -3.58%
May 7, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $107.07
Upside: -1.93%
May 7, 2026
Maintained: Buy
Price Target: $30 → $33
Current: $26.64
Upside: +23.87%
May 7, 2026
Maintained: Hold
Price Target: $16 → $32
Current: $98.43
Upside: -67.49%
May 7, 2026
Maintained: Buy
Price Target: $26
Current: $24.67
Upside: +5.39%
May 5, 2026
Maintained: Buy
Price Target: $90
Current: $84.61
Upside: +6.37%
May 5, 2026
Maintained: Buy
Price Target: $14
Current: $19.20
Upside: -27.08%
May 1, 2026
Reiterated: Buy
Price Target: $240
Current: $229.35
Upside: +4.64%
May 1, 2026
Maintained: Buy
Price Target: $300
Current: $301.17
Upside: -0.39%
Apr 30, 2026
Maintained: Hold
Price Target: $6
Current: $8.91
Upside: -32.66%
Apr 30, 2026
Maintained: Buy
Price Target: $27
Current: $23.13
Upside: +16.76%
Apr 30, 2026
Maintained: Buy
Price Target: $45
Current: $75.11
Upside: -40.09%
Apr 29, 2026
Maintained: Hold
Price Target: $195 → $250
Current: $381.15
Upside: -34.41%
Apr 20, 2026
Maintained: Hold
Price Target: $210
Current: $231.84
Upside: -9.42%
Apr 8, 2026
Maintained: Hold
Price Target: $15 → $13
Current: $13.02
Upside: -0.15%
Apr 8, 2026
Maintained: Buy
Price Target: $225 → $185
Current: $213.22
Upside: -13.24%
Mar 30, 2026
Maintained: Hold
Price Target: $3
Current: $2.15
Upside: +39.53%
Oct 27, 2025
Maintained: Buy
Price Target: $240 → $220
Current: $168.78
Upside: +30.35%
Aug 9, 2022
Maintained: Hold
Price Target: $9 → $8.5
Current: $1.36
Upside: n/a
May 6, 2022
Maintained: Hold
Price Target: $2.5 → $3
Current: $0.7248
Upside: n/a